Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04370782 · ClinicalTrials.gov registry record · Phase 4
Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
A Phase 4 study, sponsored by St. Francis Hospital, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT04370782 is a Phase 4 study that has completed, run by St. Francis Hospital, New York. The registered enrollment target is 18 participants.
The verdict
NCT04370782, a Phase 4 study, has completed, sponsored by St. Francis Hospital, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a randomized, open-label trial to assess the safety and efficacy of hydroxychloroquine, and zinc in combination with either azithromycin or doxycycline in a higher risk COVID-19 positive outpatient population.
Interventions
- DRUG Azithromycin
- DRUG Doxycycline
- DRUG Hydroxychloroquine
- DRUG Zinc Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-04-28 |
| Est. Completion | 2020-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04370782
The ClinicalTrials.gov registry entry for NCT04370782 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Francis Hospital, New York, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Azithromycin is the first listed.
NCT04370782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04370782 about?
NCT04370782 is a clinical study titled "Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting". This is a randomized, open-label trial to assess the safety and efficacy of hydroxychloroquine, and zinc in combination with either azithromycin or doxycycline in a higher risk COVID-19 positive outpatient population.
What is the current status of trial NCT04370782?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2020-04-28. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT04370782?
The interventions under investigation include: Azithromycin (DRUG), Doxycycline (DRUG), Hydroxychloroquine (DRUG), Zinc Sulfate (DRUG).
Who is sponsoring clinical trial NCT04370782?
This trial is sponsored by St. Francis Hospital, New York, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.